<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-055767</identifier>
<setSpec>0365-6691</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Traumatic submacular hemorrhage treated with rt-PA and SF6</dc:title>
<dc:description xml:lang="en">Case report: This patient was afflicted by a traumatic    submacular hemorrhage. A posterior vitrectomy    was performed and intravitreal rt-PA and SF6    were administered. Four weeks later, the visual    acuity had increased from 0.1 to 0.8. No complications    due to the treatment with rt-PA were reported.    Discussion: It is known that waiting for the spontaneous    blood removal in such cases results in a poor    visual acuity recovery due to a toxic effect of the    blood products. Both rt-PA and the SF6 are useful    for the treatment of submacular hemorrhages    secondary to age-related macular degeneration, and    this case report has shown they are also useful to    lyse traumatic blood clots, thus contributing to a    better recovery of visual acuity</dc:description>
<dc:creator>Heras Mulero, H</dc:creator>
<dc:creator>García Gómez, PJ</dc:creator>
<dc:creator>García Layana, A</dc:creator>
<dc:creator>Salinas Alamán, A</dc:creator>
<dc:creator>Sádaba Echarri, LM</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Caso clínico: Paciente que presenta hemorragia    submacular de origen traumático. Se realiza vitrectomía    posterior y administración intravítrea de rt-    PA y SF6. A las cuatro semanas la agudeza visual    había pasado de 0,1 a 0,8. El paciente no presentó    ninguna complicación derivada del tratamiento con    rt-PA    Discusión: Debido a que la sangre es tóxica para la    retina esperar a su reabsorción espontánea comporta    una pobre recuperación visual. El rt-PA administrado    junto al SF6 es útil para el tratamiento de    hemorragias submaculares secundarias a degeneración    macular asociada a la edad, pero también puede    ser útil para la lisis de coágulos hemáticos traumáticos    favoreciendo la recuperación de la agudeza    visual</dc:description>
<dc:source>Arch Soc Esp Oftalmol;82(8): 517-520, ago. 2007. ilus</dc:source>
<dc:identifier>ibc-055767</dc:identifier>
<dc:title xml:lang="es">Hemorragia submacular traumática tratada con rt-PA y SF6</dc:title>
<dc:subject>^d3162</dc:subject>
<dc:subject>^d28016^s22012</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d29770</dc:subject>
<dc:subject>^d22656^s22027</dc:subject>
<dc:subject>^d5478^s22000</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d22656^s22057</dc:subject>
<dc:subject>^d22656^s22009</dc:subject>
<dc:subject>^d331</dc:subject>
<dc:subject>^d30438^s22000</dc:subject>
<dc:subject>^d15223^s22045</dc:subject>
<dc:type>article</dc:type>
<dc:date>200708</dc:date>
</metadata>
</record>
</ibecs-document>
